We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Westwood Holdings Group
WHG
$180M
| $880K | ﹤0.01% |
16,563
-15,093
| -48% | -$790K |
2016 Q2
1 quarter
|
|
2152
ArcBest
ARCB
$2.91B
| $879K | ﹤0.01% |
46,205
-2,200
| -5% | -$39.8K |
2016 Q2
1 quarter
|
|
2153
GSK
GSK
$103B
| $878K | ﹤0.01% |
16,278
-57,413
| -78% | -$3.15M |
2016 Q2
1 quarter
|
|
2154
John Wiley & Sons Class A
WLY
$2.74B
| $878K | ﹤0.01% |
17,004
-13,226
| -44% | -$724K |
2016 Q2
1 quarter
|
|
|
SKIS
2155
DELISTED
Peak Resorts, Inc.
SKIS
| $874K | ﹤0.01% |
171,713
-16,000
| -9% | -$77.4K |
2016 Q2
1 quarter
|
|
|
COVS
2156
DELISTED
Covisint Corporation
COVS
| $874K | ﹤0.01% |
401,100
-18,811
| -4% | -$41.1K |
2016 Q2
1 quarter
|
|
2157
Great Elm Group
GEG
$63.9M
| $873K | ﹤0.01% |
186,208
| – | – |
2016 Q2
1 quarter
|
|
|
SCLN
2158
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $873K | ﹤0.01% |
85,139
+25,527
| +43% | +$278K |
2016 Q2
1 quarter
|
|
2159
Marcus & Millichap
MMI
$1.07B
| $871K | ﹤0.01% |
33,280
-5,891
| -15% | -$156K |
2016 Q2
1 quarter
|
|
2160
GATX Corp
GATX
$5.91B
| $869K | ﹤0.01% |
19,511
-21,650
| -53% | -$954K |
2016 Q2
1 quarter
|
|
|
CYBE
2161
DELISTED
Cyberoptics Corp
CYBE
| $868K | ﹤0.01% |
+35,300
| New | +$679K |
2016 Q3
0 quarters
|
|
2162
Star Group
SGU
$426M
| $866K | ﹤0.01% |
89,684
| – | – |
2016 Q2
1 quarter
|
|
2163
AeroVironment
AVAV
$5.98B
| $865K | ﹤0.01% |
35,433
+3,800
| +12% | +$102K |
2016 Q2
1 quarter
|
|
2164
Berkshire Hathaway Class A
BRK.A
$1.17T
| $865K | ﹤0.01% |
4
-1
| -20% | -$219K |
2016 Q2
1 quarter
|
|
|
DGI
2165
DELISTED
DigitalGlobe Inc.
DGI
| $863K | ﹤0.01% |
31,371
+18,676
| +147% | +$479K |
2016 Q2
1 quarter
|
|
2166
American Assets Trust
AAT
$1.31B
| $857K | ﹤0.01% |
19,760
+18,946
| +2,328% | +$839K |
2016 Q2
1 quarter
|
|
2167
AutoNation
AN
$5.35B
| $857K | ﹤0.01% |
17,608
+3,580
| +26% | +$176K |
2016 Q2
1 quarter
|
|
|
CUDA
2168
DELISTED
Barracuda Networks, Inc.
CUDA
| $855K | ﹤0.01% |
+33,557
| New | +$737K |
2016 Q3
0 quarters
|
|
2169
Perdoceo Education
PRDO
$2.12B
| $847K | ﹤0.01% |
124,713
+94,713
| +316% | +$644K |
2016 Q2
1 quarter
|
|
2170
Chegg
CHGG
$74.4M
| $842K | ﹤0.01% |
+118,712
| New | +$760K |
2016 Q3
0 quarters
|
|
2171
BOK Financial
BOKF
$7.84B
| $840K | ﹤0.01% |
12,182
+95
| +0.8% | +$6.3K |
2016 Q2
1 quarter
|
|
|
LOXO
2172
DELISTED
Loxo Oncology, Inc
LOXO
| $839K | ﹤0.01% |
32,042
-7,570
| -19% | -$198K |
2016 Q2
1 quarter
|
|
2173
Donaldson
DCI
$10B
| $838K | ﹤0.01% |
22,450
-9,793
| -30% | -$357K |
2016 Q2
1 quarter
|
|
|
PTHN
2174
DELISTED
Patheon N.V.
PTHN
| $838K | ﹤0.01% |
+28,256
| New | +$774K |
2016 Q3
0 quarters
|
|
2175
Stifel
SF
$10.2B
| $837K | ﹤0.01% |
48,958
-92,243
| -65% | -$1.48M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.